Clinical and cost‐effectiveness of non‐invasive cell‐free <scp>DNA</scp> testing to optimise foetal outcomes for women with monogenic diabetes due to inactivating glucokinase gene mutations: a case series
NIPT has the potential to improve diagnostic uncertainty associated with the management of GCK-MODY in pregnancy, reduce the economic and personal burden of intensive foetal monitoring and improve perinatal outcomes.
Authors
- Christopher J. Yates (ORCID: https://orcid.org/0000-0003-4559-4482)
- I‐Lynn Lee (ORCID: https://orcid.org/0000-0001-9958-8489)
- Devaang Kevat
- Annabel S. Jones (ORCID: https://orcid.org/0000-0002-1266-0220)
- K.J. Goh
Institutions
- The University of Melbourne (AU)
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists (AU)
- Western Health (AU)
- Victoria University (AU)
Publication Details
- Journal
- Internal Medicine Journal
- Published
- 2025-11-20
- DOI
- https://doi.org/10.1111/imj.70262
- Primary Topic
- Prenatal Screening and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00